US Patent Issued to Laboratory Corporation of America Holdings on July 14 for "Methods of quality control using single-nucleotide polymorphisms in pre-implantation genetic screening" (Massachusetts Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,682,983, issued on July 14, was assigned to Laboratory Corporation of America Holdings (Burlington, N.C.).

"Methods of quality control using single-nucleotide polymorphisms in pre-implantation genetic screening" was invented by Mark Umbarger (Brookline, Mass.), Athurva Gore (Cambridge, Mass.) and Gregory Porreca (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for validating results of a pre-implantation genetic screen. Methods of the invention increase the efficacy of the common PGS assay FAST-SeqS by taking advantage of single-nucleotide polymorphisms (SNPs) generated from the assay to confirm cop...